here's the deal - i'm long this stock for a long time now, and i think the drug has great potential. my gut is that is why all longs are here - we believe in Leronlimab. and when you look at the backdrop (BP needing new molecules) - we would seem to be in the catbird seat.

but i think this company has been (and continues to be) terribly mis-managed - honestly, i welcome anyone on the board to counter that.

so when people say they are tired of the lack of communication and total lack of leadership by the people who are supposed to be the stewards of our investment dollars, we are "bashers" or "trying to drive the price down" - how is that? and how is everyone not pissed off about the fact that we as shareholders are treated so poorly?

we have a potentially great drug that is being horribly mis-managed. that's the bottom line as i see it.